Bed Rest on the Effect of CSF Leakage Repair After Transsphenoidal Pituitary Surgery

The Impact of Postoperative Bed Rest on the Repair of Cerebrospinal Fluid (CSF) Leakage After Transnasal Transsphenoidal Pituitary Surgery

Postoperative cerebrospinal fluid (CSF) leakage is a well-known complication that might occur after transnasal transsphenoidal adenomectomy at an incidence of 0.5-15% according to different literature reports. Persistent CSF leakage may lead to intracranial hypotension or meningitis, therefore aggressive management is mandatory. The treatment is immediate repair during transsphenoidal surgery once intraoperative CSF leakage is identified, with the adjunct of postoperative bed rest and/or lumbar drainage. However, due to the advances in endoscopic endonasal skull base surgery, some surgical teams have advocated that postoperative bed rest may not be necessary if appropriate repair have been performed. High-flow CSF leakage typically occurs in an extended endonasal approach to the anterior or posterior cranial fossa, whereas CSF leakage resulting from transsphenoidal pituitary surgery is usually easier to be repaired.

Bed rest is stressful management for patients and poses increased risks in many ways, such as the need for an indwelling urinary catheter, musculoskeletal pain, affected sleep quality, and increased possibility of thromboembolism. It is crucial that the duration of bed rest be cut short or totally avoided if clinically acceptable. In reviewing the literature, there is insufficient evidence supporting the routine use of postoperative bed rest after CSF leakage repair in transsphenoidal surgery. This study aims to compare the efficacy of successful CSF leakage repair with or without postoperative bed rest with an open-label randomized trial design.

Study Overview

• Status: Enrolling by invitation
• Conditions: CSF Leakage; Adenoma Pituitary
• Intervention / Treatment: Other: Bed rest

Detailed Description

Postoperative CSF leakage is a well-known complication that might occur after transnasal transsphenoidal adenomectomy at an incidence of 0.5-15% according to different literature reports. Persistent CSF leakage may lead to intracranial hypotension or meningitis, therefore aggressive management is mandatory. The reason that a postoperative CSF leakage would occur mostly is due to the rupture of arachnoid membrane caused by intraoperative manipulation, resulting in direct communication between the subarachnoid space and the nasal cavity. Even when in cases without intraoperative CSF leakage detected, there is a reported incidence of 1.3% of postoperative CSF leakage.

The rate of intraoperative CSF leakage varies in different tumor sizes, tumor extents, tumor natures, and surgical teams, and it could not be precisely documented as 23.3-60% were reported. The treatment is immediate repair during transsphenoidal surgery once intraoperative CSF leakage is identified, with the adjunct of postoperative bed rest and/or lumbar drainage. However, due to the advances in endoscopic endonasal skull base surgery, some surgical teams have advocated that postoperative bed rest may not be necessary if appropriate repair have been performed. High-flow CSF leakage typically occurs in an extended endonasal approach to the anterior or posterior cranial fossa, whereas CSF leakage resulting from transsphenoidal pituitary surgery is usually easier to be repaired.

Bed rest is stressful management for patients and poses increased risks in many ways, such as the need for an indwelling urinary catheter, musculoskeletal pain, affected sleep quality, and increased possibility of thromboembolism. It is crucial that the duration of bed rest be cut short or totally avoided if clinically acceptable. In reviewing the literature, there is insufficient evidence supporting the routine use of postoperative bed rest after CSF leakage repair in transsphenoidal surgery. This study aims to compare the efficacy of successful CSF leakage repair with or without postoperative bed rest with an open-label randomized trial design.

• Study Type: Interventional
• Enrollment (Estimated): 180
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Huan-Chih Wang, MD; Phone Number: +886972655831; Email: jessehcwang@ntu.edu.tw

Study Locations

• Taiwan
  • Taipei, Taiwan
    • Division of Neurosurgery, Department of Surgery, National Taiwan University Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 20 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Patients with pituitary adenoma requiring surgical resection.

Exclusion Criteria:

• Spontaneous CSF leakage occurs prior to transsphenoidal surgery.
• The growth of adenoma extends to anterior cranial fossa or clival region.
• The growth of adenoma extends to 3rd ventricle.
• Prior history of transsphenoidal surgery.
• Prior history of radiotherapy or radiosurgery to the sella or nearby skull base region.
• Class 2 obesity or extremely obese: BMI ≧35.
• Pregnant or lactating women.
• Patients who could not give informed consent.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

5

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Prospective experimental - no bed rest after intraoperative leak; Randomized after surgery if intraoperative CSF leakage occurs. The ratio for allocating into arm 1 vs. arm 2 is 2:1.
Active Comparator: Prospective control - bed rest after intraoperative leak; Randomized after surgery if intraoperative CSF leakage occurs. The ratio for allocating into arm 1 vs. arm 2 is 2:1.	Other: Bed rest; Strict bed rest ordered after surgery that does not allow the participant to elevate the head of bed over 30 degrees
No Intervention: Prospective control - no bed rest after no intraoperative leak; Enters this arm if no intraoperative CSF leakage occurs.
Active Comparator: Retrospective control - bed rest after intraoperative leak; Historical control, bed rest applied after intraoperative CSF leakage.	Other: Bed rest; Strict bed rest ordered after surgery that does not allow the participant to elevate the head of bed over 30 degrees
No Intervention: Retrospective control - no bed rest after no intraoperative leak; Historical control, bed rest not applied after no intraoperative CSF leakage.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Occurrence of CSF leakage within 3 months postoperatively	Any documented CSF leakage within 3 months postoperatively. Confirmation of CSF leakage could either be: typical symptoms of CSF rhinorrhea, plus visible clear and colorless rhinorrhea with positive glucose response; atypical symptoms of CSF rhinorrhea, plus visualization of clear and colorless fluid from the operative site via sinoscope; atypical symptoms of CSF rhinorrhea, plus identifiable fluid accumulation in the sphenoid sinus and suspicious site of CSF fistula via neuroimaging modalities	12 weeks after the date of surgery

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Occurrence of meningitis within 3 months postoperatively	Any documented meningitis within 3 months postoperatively.	12 weeks after the date of surgery
Length of hospital stay	The length of stay is calculated from 1 day prior to surgery until the day of discharge.	24 weeks after the date of surgery
Results of 36-Item short form health survey (SF-36) surveys	SF-36 with its 8 subscales as well as the physical component summary (PCS) and mental component summary (MCS) scores. Each of the 8 subscales (physical functioning [PF], role physical [RP], bodily pain [BP], general health [GH], vitality [VT], social functioning [SF], role emotional [RE], and mental health [MH]) has a minimum value of 0 and maximum value of 100, a higher score relates to a better outcome. The PCS score is the average score of PF, RP, BP, and GH, while the MCS score is the average score of VT, SF, RE, and MH (both has the minimum value of 0 and maximum value of 100, a higher score relates to a better outcome).	On postoperative day 1, postoperative day 7, postoperative day 28, postoperative week 12 and postoperative week 24.

Collaborators and Investigators

• Sponsor: National Taiwan University Hospital

Study record dates

Study Major Dates

• Study Start (Actual): March 2, 2023
• Primary Completion (Estimated): December 31, 2024
• Study Completion (Estimated): December 31, 2025

Study Registration Dates

• First Submitted: December 27, 2022
• First Submitted That Met QC Criteria: December 27, 2022
• First Posted (Actual): January 12, 2023

Study Record Updates

• Last Update Posted (Actual): March 8, 2023
• Last Update Submitted That Met QC Criteria: March 6, 2023
• Last Verified: December 1, 2022

More Information

Terms related to this study

• Keywords: bed rest; CSF leakage; transsphenoidal adenomectomy
• Additional Relevant MeSH Terms: Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Neoplasms by Histologic Type; Neoplasms; Neoplasms, Glandular and Epithelial; Neurologic Manifestations; Wounds and Injuries; Endocrine System Diseases; Craniocerebral Trauma; Trauma, Nervous System; Hypothalamic Diseases; Adenoma; Pituitary Diseases; Cerebrospinal Fluid Leak
• Other Study ID Numbers: 202207083RINA

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No